Gamco Investors INC. ET AL raised its stake in Bausch Health Companies Inc. (NYSE:BHC – Free Report) by 4.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,440,945 shares of the company’s stock after acquiring an additional 63,700 shares during the period. Gamco Investors INC. ET AL’s holdings in Bausch Health Companies were worth $11,528,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Commonwealth Equity Services LLC boosted its stake in shares of Bausch Health Companies by 69.7% during the 2nd quarter. Commonwealth Equity Services LLC now owns 39,300 shares of the company’s stock worth $314,000 after purchasing an additional 16,148 shares during the period. Dimensional Fund Advisors LP increased its stake in Bausch Health Companies by 12.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,733,882 shares of the company’s stock valued at $21,870,000 after purchasing an additional 309,522 shares in the last quarter. TD Asset Management Inc boosted its holdings in shares of Bausch Health Companies by 1.8% in the 2nd quarter. TD Asset Management Inc now owns 967,716 shares of the company’s stock valued at $7,752,000 after acquiring an additional 17,113 shares during the last quarter. Parallel Advisors LLC boosted its holdings in shares of Bausch Health Companies by 57.4% in the 2nd quarter. Parallel Advisors LLC now owns 3,262 shares of the company’s stock valued at $26,000 after acquiring an additional 1,189 shares during the last quarter. Finally, Atria Wealth Solutions Inc. boosted its holdings in shares of Bausch Health Companies by 13.4% in the 2nd quarter. Atria Wealth Solutions Inc. now owns 30,377 shares of the company’s stock valued at $243,000 after acquiring an additional 3,600 shares during the last quarter. 74.56% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Bausch Health Companies
In other Bausch Health Companies news, EVP Seana Carson sold 6,685 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $8.28, for a total transaction of $55,351.80. Following the sale, the executive vice president now directly owns 385,213 shares of the company’s stock, valued at approximately $3,189,563.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 13.75% of the stock is owned by corporate insiders.
Bausch Health Companies Stock Performance
Analysts Set New Price Targets
BHC has been the topic of a number of recent analyst reports. StockNews.com downgraded shares of Bausch Health Companies from a “buy” rating to a “hold” rating in a report on Wednesday, October 18th. Jefferies Financial Group raised shares of Bausch Health Companies from a “hold” rating to a “buy” rating and boosted their price target for the company from $9.00 to $16.00 in a research note on Wednesday, September 20th. Finally, Royal Bank of Canada lifted their price objective on shares of Bausch Health Companies from $8.00 to $9.00 and gave the company a “sector perform” rating in a report on Monday, July 24th.
About Bausch Health Companies
Bausch Health Companies Inc operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
- Five stocks we like better than Bausch Health Companies
- How to Invest in Artificial Intelligence
- Safeguard your portfolio with these three bargain stocks
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Membership clubs gain leverage for the consumer rebound
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Advanced Auto Parts may be worth more in pieces than the whole
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.